Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CIP2A/p90 Autoantigen Polyclonal Antibody

😃Good
Catalog No. TMAB-04358

Anti-CIP2A/p90 Autoantigen Polyclonal Antibody is a Rabbit antibody targeting CIP2A/p90 Autoantigen. Anti-CIP2A/p90 Autoantigen Polyclonal Antibody can be used in ICC/IF,FCM.

Anti-CIP2A/p90 Autoantigen Polyclonal Antibody

Anti-CIP2A/p90 Autoantigen Polyclonal Antibody

😃Good
Catalog No. TMAB-04358
Anti-CIP2A/p90 Autoantigen Polyclonal Antibody is a Rabbit antibody targeting CIP2A/p90 Autoantigen. Anti-CIP2A/p90 Autoantigen Polyclonal Antibody can be used in ICC/IF,FCM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 μL$2237-10 days7-10 days
100 μL$3737-10 days7-10 days
200 μL$5297-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-CIP2A/p90 Autoantigen Polyclonal Antibody is a Rabbit antibody targeting CIP2A/p90 Autoantigen. Anti-CIP2A/p90 Autoantigen Polyclonal Antibody can be used in ICC/IF,FCM.
Ig Type
IgG
Reactivity
Human (predicted:Mouse,Rat,Dog,Cow,Rabbit)
Application
Recommended Dose
ICC/IF: 1:100-500; FCM: 1μg/Test
Antibody Type
Polyclonal
Host SpeciesRabbit
Subcellular LocalizationMembrane; Single-pass membrane protein (Potential). Cytoplasm. Note=Slightly concentrates in the perinuclear region.
Tissue SpecificityExpressed at low levels in most of the tissues. Overexpressed in head-and-neck squamous cell carcinomas (HNSCC). Present in liver cancer cells (at protein level).
ConstructionPolyclonal Antibody
PurificationProtein A purified
AppearanceLiquid
Formulation0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Concentration1mg/ml
Research BackgroundInhibition of protein phosphatase 2A (PP2A) activity has been identified as a prerequisite for the transformation of human cells. The protein, designated Cancerous Inhibitor of PP2A (CIP2A, p90 Autoantigen), interacts directly with the oncogenic transcription factor c-Myc, inhibits PP2A activity toward c-Myc serine 62 (S62), and thereby prevents c-Myc proteolytic degradation. In addition to its function in c-Myc stabilization, p90 Autoantigen promotes anchorage-independent cell growth and in vivo tumor formation. The oncogenic activity of p90 Autoantigen is demonstrated by transformation of human cells by overexpression of p90 Autoantigen. Importantly, p90 Autoantigen is overexpressed in two common human malignancies, head and neck squamous cell carcinoma (HNSCC) and colon cancer.
Antigen Details
Immunogen
KLH conjugated synthetic peptide: human p90 Autoantigen
Antigen Species
Human
Gene Name
CIP2A
Gene ID
Protein Name
Protein CIP2A
Uniprot ID
Chemical Properties
Molecular WeightTheoretical: 100 kDa.
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-CIP2A/p90 Autoantigen Polyclonal Antibody | purchase Anti-CIP2A/p90 Autoantigen Polyclonal Antibody | Anti-CIP2A/p90 Autoantigen Polyclonal Antibody cost | order Anti-CIP2A/p90 Autoantigen Polyclonal Antibody | Anti-CIP2A/p90 Autoantigen Polyclonal Antibody molecular weight